Zuclopenthixol ong-acting IM Injection (Depot)
Form: Long-acting IM Injection (Depot)
Strength: 200 mg/mL, 500 mg/mL
Reference Brands: Clopixol Depot®(US)
Category: Antipsychotropic Drugs
Zuclopenthixol long-acting IM injection, a typical antipsychotic depot formulation, is not FDA-approved in the United States but is widely authorized in the EU under the brand Clopixol Depot. In Europe, it follows EMA guidelines for long-acting injectable neuroleptics, indicated for schizophrenia and related psychoses. EU compliance requires GMP manufacturing, stability data, and pharmacovigilance alignment. U.S. market entry may involve a 505(b)(2) pathway and complete ANDA dossier. To explore dossier-ready forms, formulations, and global suppliers of Zuclopenthixol long-acting IM injection, visit Pharmatradz.com.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Risperidone Long-Acting Injection
Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg vials/syringes
Form: Long-Acting Injection
Reference Brands: Risperdal Consta(US &EU)
View Details Get Enquiry
Zuclopenthixol Short-acting Intramuscular Injection
Strength: 50 mg/mL
Form: Short-acting Intramuscular Injection
Reference Brands: Clopixol-Acuphase®
View Details Get Enquiry
Zuclopenthixol tablets
Strength: 10 mg, 25 mg, 40 mg
Form: Oral Tablets
Reference Brands: Clopixol®(EU)
View Details Get Enquiry
Pimozide Tablets
Strength: 1 mg, 2 mg, 4 mg
Form: Oral Tablets
Reference Brands: Orap®(US & EU)
View Details Get Enquiry